Skip to main content

IMCR Immunocore Holdings plc

Healthcare

29.39

Close 10/9

Open
29.06
High
29.73
Low
29.03
Prev close
29.09
Volume
452.8K
52W 27.56 40.71
Loading candles…

Is Immunocore Holdings plc a buy? Fundamentals and valuation first

As of 2026-10-09

Risk / liquidity: Good.

Momentum Neutral All 2 indicators are Average.
60-day return (%) -14.74 29th percentile Average
240-day return (%) -11.21 43th percentile Average
Risk / liquidity Good All 2 indicators are Good.
20-day dollar volume 13,705,752 68th percentile Good
60-day annualized volatility (%) 28.59 32th percentile Good

Immunocore Holdings plc (IMCR) peers and tracking

Watchlist

This page refreshes daily after the close. Add Immunocore Holdings plc to your watchlist to track signal changes on your next visit.

Immunocore Holdings plc (IMCR) quant signal backtests

Market-wide momentum baseline

Across 98,394 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.23%, a 57.8% positive-return rate, and +2.88 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

More history: Signals not active now

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

7 times historically; 60-day forward avg -10.01%, win rate 28.6%, beating the market by -11.75 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

7 times historically; 60-day forward avg +1.04%, win rate 28.6%, beating the market by -4.41 pts on average.

Continue researching Immunocore Holdings plc with the evidence above.

Continue in Studio ↗

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.
  • This is an American depositary receipt (ADR). The data does not say how many ordinary shares each ADR represents, so per-share and market-value metrics (P/E, price/book, free-cash-flow yield, EPS growth and earnings surprises) are not computed.
  • ADRs listed on NYSE or NASDAQ are covered as a separate group selected by dollar volume, in addition to the common-stock universe; the 6-month momentum signal ranks each ADR against the liquid US common stocks.
  • The company has reported its financial statements in more than one currency, so margins, growth and valuation figures that would combine them are not computed.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.